Drug Description in Trials / DrugBank / KEGG DRUG


Search results


No. Drug (Description in trials) DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY Disease ID
1Acetylcysteine[1] Acetylcysteine[1] Acetylcysteine 💬 --[10] 34, 51, 53, 85, 94, 97, 193, 233, 298, 299 💬
2AMX0035----[3] 2, 5, 233 💬
3Dantrolene sodium[1] Dantrolene[2] Dantrolene sodium ,
Dantrolene 💬
--[1] 233 💬
4Deferiprone[1] Deferiprone[1] Deferiprone 💬 --[7] 2, 6, 18, 121, 122, 139, 233 💬
5Depakine----[2] 102, 233 💬
6Depakine chrono 500 MG----[1] 233 💬
7Depakine chrono® 500 MG----[1] 233 💬
8Exenatide[1] Exenatide[1] Exenatide 💬 [1] GLP1R 💬 [4] Hormone signaling, Insulin secretion, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬[5] 6, 17, 78, 193, 233 💬
9Mounjaro - tirzepatide[1] Tirzepatide[1] Tirzepatide 💬 [2] GIPR,
GLP1R 💬
[4] Hormone signaling, Insulin secretion, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬[1] 233 💬
10Sitagliptin and metformin[1] Sitagliptin[3] Sitagliptin phosphate ,
Sitagliptin ,
Sitagliptin phosphate 💬
[1] DPP4 💬 [2] Protein digestion and absorption, Virion - Hepatitis viruses 💬[1] 233 💬
11Sodium valproate 200 MG gastro-resistant tablets----[1] 233 💬
12Sodium valproate 200MG E/C tablet----[1] 233 💬
13Sodium valproate wockhardt 200MG gastro-resistant tablets----[1] 233 💬
14Tirzepatide[1] Tirzepatide[1] Tirzepatide 💬 [2] GIPR,
GLP1R 💬
[4] Hormone signaling, Insulin secretion, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬[5] 67, 96, 97, 193, 233 💬